Home › Therapeutic areas › Oncology › Esophageal Cancer

Esophageal Cancer (3 companies)

Companies with an active program in Esophageal Cancer.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
CHRS Coherus Oncology Oncology 1 Approved $74.0M 5
KAPA Kairos Pharma Oncology 1 Phase 2 $1.9M 12
LEGN Legend Biotech Oncology Rare 1 Approved $3.12B 17